Journal ArticleOmega (Westport) · February 2025
The life-limiting and unpredictable nature of sickle cell disease (SCD) is well-established, yet there is limited literature on end-of-life planning. The purpose of this study was to describe perspectives about preparing for death for older adults with SCD ...
Full textLink to itemCite
Journal ArticleJ Sick Cell Dis · 2025
OBJECTIVES: More individuals with SCD are living beyond initial life expectancy. Despite a growing population of older adults with SCD, little is known about their unique experiences and needs. Understanding the perspectives of older adults with SCD (age ≥ ...
Full textLink to itemCite
Journal ArticleJ Gerontol A Biol Sci Med Sci · November 1, 2024
BACKGROUND: Sickle cell disease (SCD) is a chronic medical condition characterized by red blood cell sickling, vaso-occlusion, hemolytic anemia, and subsequently, end-organ damage and reduced survival. Because of this significant pathophysiology and early ...
Full textLink to itemCite
Journal ArticleJ Neurosurg Case Lessons · June 10, 2024
BACKGROUND: Essential tremor (ET) is one of the most common movement disorders worldwide. In medically refractory ET, deep brain stimulation (DBS) of the ventral intermediate nucleus of the thalamus is the current standard of care. However, DBS carries an ...
Full textLink to itemCite
Journal ArticleBlood · January 18, 2024
With the global growing older adult population, clinicians face the common, yet complex challenge of how to evaluate and manage anemia in this population. Older age predisposes to common causes of anemia such as nutritional deficiencies, inflammatory disor ...
Full textLink to itemCite
Journal ArticleGait Posture · May 2023
BACKGROUND: Sickle cell disease (SCD) is a genetic disorder that causes physical and cognitive impairment due to hemolysis, painful vaso-occlusion episodes, joint avascular necrosis, and strokes. As individuals with SCD age and develop conditions impacting ...
Full textLink to itemCite
Journal ArticleDrugs Aging · April 2023
People with sickle cell disease (SCD) are living longer than ever before, with the median survival increasing from age 14 years in 1973, beyond age 40 years in the 1990s, and as high as 61 years in recent cohorts from academic centers. Improvements in surv ...
Full textLink to itemCite
Journal ArticleBr J Haematol · March 2023
Individuals with sickle cell disease (SCD) have historically been considered underweight. Despite increasing body mass index (BMI) in the general population, the prevalence of overweight and obese status remains unclear in the adult SCD population. Our pri ...
Full textLink to itemCite
Journal ArticlePilot Feasibility Stud · March 4, 2022
BACKGROUND: The life expectancy for individuals with sickle cell disease (SCD) has greatly increased over the last 50 years. Adults with SCD experience multiple complications such as cardiopulmonary disease, strokes, and avascular necrosis that lead to lim ...
Full textOpen AccessLink to itemCite
Journal ArticleHematology Am Soc Hematol Educ Program · December 10, 2021
Individuals with sickle cell disease (SCD) are likely to be referred for surgery at some point in their lifetime due to a high incidence of musculoskeletal and intrabdominal complications such as avascular necrosis and gallbladder disease. Preoperative opt ...
Full textLink to itemCite
Journal ArticleJ Natl Med Assoc · April 2021
BACKGROUND: Individuals with hemoglobinopathies experience complications that often require management with multiple transfusions. These chronic transfusions can lead to iron overload, which places them at increased risk of organ damage, malignancy, and ev ...
Full textLink to itemCite
Journal ArticlePilot Feasibility Stud · 2020
BACKGROUND: The life expectancy for people with sickle cell disease (SCD) has improved tremendously over the last 50 years. This population experiences hemolysis and vaso-occlusion in multiple organs that lead to complications such as cardiopulmonary disea ...
Full textLink to itemCite
Journal ArticleBlood · November 13, 2019
BackgroundDuring the last five decades the life expectancy for people living with sickle cell disease (SCD) has improved markedly, with median survival of 61 years in recent cohorts enrolle ...
Full textOpen AccessCite